Andrew W. Boyd
300 Herston Rd
Brisbane, QLD 4006, Australia
Brisbane, QLD 4006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study.
Journal: Clinical drug investigation
Published: November 04, 2024
Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis.
Journal: Science translational medicine
Published: April 24, 2024
FKRP directed fibronectin glycosylation: A novel mechanism giving insights into muscular dystrophies?
Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: November 10, 2021
Role of EphA4 in Mediating Motor Neuron Death in MND.
Journal: International journal of molecular sciences
Published: July 20, 2021
Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.
Journal: Scientific reports
Published: January 23, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies.
Journal: ACS central science
Published: December 18, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular niche.
Journal: Acta neuropathologica
Published: May 09, 2019
T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
Journal: Haematologica
Published: December 06, 2018
Last Updated: 09/26/2026